LeonaBio, Inc. Shares Outstanding (Cover Page)
LeonaBio, Inc. (LONA) had Shares Outstanding (Cover Page) of 9.42 million shares as of 2026-08-04, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-04: Entity Common Stock, Shares Outstanding 9.42M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 9.39M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 3.94M shares.
- 2025-08-05: Entity Common Stock, Shares Outstanding 39.44M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 9.42M shares 10-Q · filed 2026-08-14 |
| 2026-05-05 | 9.39M shares 10-Q · filed 2026-05-07 |
| 2025-11-05 | 3.94M shares 10-Q · filed 2025-11-06 |
| 2025-08-05 | 39.44M shares 10-Q · filed 2025-08-07 |
| 2025-05-06 | 39.04M shares 10-Q · filed 2025-05-09 |
| 2025-02-24 | 39.04M shares 10-K · filed 2025-02-27 |
| 2024-11-04 | 38.67M shares 10-Q · filed 2024-11-07 |
| 2024-07-29 | 38.44M shares 10-Q/A · filed 2024-08-09 |
| 2024-05-10 | 38.33M shares 10-Q · filed 2024-05-15 |
| 2024-02-19 | 38.33M shares 10-K · filed 2024-02-22 |
| 2023-11-06 | 38.05M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 38.05M shares 10-Q · filed 2023-08-10 |
| 2023-05-08 | 37.95M shares 10-Q · filed 2023-05-11 |
| 2023-03-20 | 37.94M shares 10-K · filed 2023-03-23 |
| 2022-11-07 | 37.83M shares 10-Q · filed 2022-11-10 |
| 2022-08-08 | 37.82M shares 10-Q · filed 2022-08-15 |
| 2022-05-09 | 37.64M shares 10-Q · filed 2022-05-12 |
| 2022-03-21 | 37.62M shares 10-K · filed 2022-03-28 |
| 2021-11-05 | 37.35M shares 10-Q · filed 2021-11-10 |
| 2021-08-09 | 37.30M shares 10-Q · filed 2021-08-16 |
| 2021-05-10 | 37.22M shares 10-Q · filed 2021-05-13 |
| 2021-03-22 | 37.12M shares 10-K · filed 2021-03-25 |
| 2020-11-09 | 32.49M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |